Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8822531rdf:typepubmed:Citationlld:pubmed
pubmed-article:8822531lifeskim:mentionsumls-concept:C0171023lld:lifeskim
pubmed-article:8822531lifeskim:mentionsumls-concept:C1276996lld:lifeskim
pubmed-article:8822531lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:8822531lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:8822531lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:8822531pubmed:issue2lld:pubmed
pubmed-article:8822531pubmed:dateCreated1997-6-30lld:pubmed
pubmed-article:8822531pubmed:abstractTextThe affinities of olanzapine, clozapine, haloperidol, and four potential antipsychotics were compared on binding to the neuronal receptors of a number of neurotransmitters. In both rat tissues and cell lines transfected with human receptors olanzapine had high affinity for dopamine D1, D2, D4, serotonin (5HT)2A, 5HT2C, 5HT3, alpha 1-adrenergic, histamine H1, and five muscarinic receptor subtypes. Olanzapine had lower affinity for alpha 2-adrenergic receptors and relatively low affinity for 5HT1 subtypes, GABAA, beta-adrenergic receptors, and benzodiazepine binding sites. The receptor binding affinities for olanzapine was quite similar in tissues from rat and human brain. The binding profile of olanzapine was comparable to the atypical antipsychotic clozapine, while the binding profiles for haloperidol, resperidone, remoxipride, Org 5222, and seroquel were substantially different from that of clozapine. The receptor binding profile of olanzapine is consistent with the antidopaminergic, antiserotonergic, and antimuscarinic activity observed in animal models and predicts atypical antipsychotic activity in man.lld:pubmed
pubmed-article:8822531pubmed:languageenglld:pubmed
pubmed-article:8822531pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8822531pubmed:citationSubsetIMlld:pubmed
pubmed-article:8822531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8822531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8822531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8822531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8822531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8822531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8822531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8822531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8822531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8822531pubmed:statusMEDLINElld:pubmed
pubmed-article:8822531pubmed:monthFeblld:pubmed
pubmed-article:8822531pubmed:issn0893-133Xlld:pubmed
pubmed-article:8822531pubmed:authorpubmed-author:SeemanPPlld:pubmed
pubmed-article:8822531pubmed:authorpubmed-author:TyeN CNClld:pubmed
pubmed-article:8822531pubmed:authorpubmed-author:WongD TDTlld:pubmed
pubmed-article:8822531pubmed:authorpubmed-author:BymasterF PFPlld:pubmed
pubmed-article:8822531pubmed:authorpubmed-author:MooreN ANAlld:pubmed
pubmed-article:8822531pubmed:authorpubmed-author:CalligaroD...lld:pubmed
pubmed-article:8822531pubmed:authorpubmed-author:NEVOTAAlld:pubmed
pubmed-article:8822531pubmed:authorpubmed-author:FalconeJ FJFlld:pubmed
pubmed-article:8822531pubmed:issnTypePrintlld:pubmed
pubmed-article:8822531pubmed:volume14lld:pubmed
pubmed-article:8822531pubmed:ownerNLMlld:pubmed
pubmed-article:8822531pubmed:authorsCompleteYlld:pubmed
pubmed-article:8822531pubmed:pagination87-96lld:pubmed
pubmed-article:8822531pubmed:dateRevised2011-5-18lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:meshHeadingpubmed-meshheading:8822531-...lld:pubmed
pubmed-article:8822531pubmed:year1996lld:pubmed
pubmed-article:8822531pubmed:articleTitleRadioreceptor binding profile of the atypical antipsychotic olanzapine.lld:pubmed
pubmed-article:8822531pubmed:affiliationLilly Research Laboratories, Indianapolis, IN 46285, USA.lld:pubmed
pubmed-article:8822531pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8822531pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8822531pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8822531lld:pubmed